71774-13-5 Usage
Uses
Used in Pharmaceutical Industry:
ADENOSINE-3',5'-CYCLIC -MONOPHOSPHOROTHIOATE is used as an activator for [application type] Protein Kinase A (PKA) for [application reason] its ability to modulate cellular signaling pathways and potentially influence various physiological processes. This activation can be utilized in the development of therapeutic strategies targeting conditions where PKA activity is implicated.
Used in Research Applications:
In the field of scientific research, ADENOSINE-3',5'-CYCLIC -MONOPHOSPHOROTHIOATE serves as a valuable tool for [application type] studying the role of adenosine and PKA in cellular processes and disease mechanisms. ADENOSINE-3',5'-CYCLIC -MONOPHOSPHOROTHIOATE can be used to [application reason] investigate the effects of PKA activation on cellular functions, providing insights into the development of novel therapeutic approaches.
Used in Drug Development:
ADENOSINE-3',5'-CYCLIC -MONOPHOSPHOROTHIOATE may also be employed in the development of new drugs targeting [application type] PKA-related conditions. By understanding the compound's interaction with PKA, researchers can [application reason] design more effective and targeted therapies for diseases where PKA plays a significant role, such as certain types of cancer or cardiovascular diseases.
Biological Activity
Cell-permeable cAMP analog that activates cAMP receptor proteins such as PKA and cAMP-regulated guanine nucleotide exchange factor.
Check Digit Verification of cas no
The CAS Registry Mumber 71774-13-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,1,7,7 and 4 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 71774-13:
(7*7)+(6*1)+(5*7)+(4*7)+(3*4)+(2*1)+(1*3)=135
135 % 10 = 5
So 71774-13-5 is a valid CAS Registry Number.
71774-13-5Relevant academic research and scientific papers
PURINE NUCLEOTIDE DERIVATIVES
-
Page/Page column 18, (2010/02/15)
This invention provides novel 8-carbyl substituted cAMPS and a novel procedures for the preparation of 8-Br-cAMP, a key starting material.
